Shanghai Juncell Therapeutics

This early-phase study tests a new treatment called GC203 TIL for people with pancreatic cancer that has not responded to standard therapies. The treatment uses a patient's own immune cells, which are collected from their tumor, genetically modified to fight cancer better, and th…

This early-stage study is testing a new treatment for people with advanced liver or pancreatic cancer who have run out of standard options. Doctors take immune cells from a patient's tumor, grow more of them in a lab, and put them back into the body to fight the cancer. The goal …

This early-phase study tests a personalized cell therapy (GC101 TIL) for people with advanced gastrointestinal tumors that have not responded to standard treatments. Doctors take immune cells from the patient's own tumor, grow them in the lab, and infuse them back after a short c…

This study tests a new treatment called GC101 TIL for people with advanced melanoma that has not responded to standard therapies. The treatment uses a patient's own immune cells taken from their tumor, grown in a lab, and then given back to fight the cancer. About 98 adults will …

This study tests a treatment that uses a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight advanced solid tumors. The cells are taken from a tumor sample, grown in a lab, and then given back to the patient. The goal is to see if this therapy is sa…

This early-stage trial tests a treatment called GC101 TIL, which uses a patient's own immune cells (tumor-infiltrating lymphocytes) to fight advanced non-small cell lung cancer. About 20 adults whose cancer has not responded to standard therapies will receive the cells and be mon…

This study tests a new treatment called TIL therapy for people with advanced breast cancer who have run out of standard options. Doctors take immune cells from a patient's own tumor, grow them in a lab, and put them back into the body to attack the cancer. The goal is to see if i…

This early-phase trial tests a therapy made from a patient's own tumor-fighting immune cells (TILs) for advanced melanoma. About 50 adults who have not responded to standard treatments will receive their own expanded TILs along with a short course of chemotherapy. The goal is to …

This early-stage study tests a treatment called TIL therapy for people with brain glioma, a type of brain cancer. Doctors take immune cells from the patient's own tumor, grow them in a lab, and put them back into the body to attack the cancer. The study involves 50 adults who hav…

This early-stage study tests a personalized cell therapy for people with advanced solid tumors that have not responded to standard treatments. Doctors take immune cells from a patient's own tumor, grow them in large numbers, and give them back through an IV. The goal is to see if…

This early-phase study tests a new treatment called GC201 TIL for people with advanced gynecologic cancers that have not responded to standard therapies. Doctors take immune cells from the patient's tumor, modify them to better fight cancer, and then return them to the body. The …

This early-phase trial tests a new treatment called GC203 TIL, which uses a patient's own immune cells that are engineered in a lab to better attack cancer. It is for people with advanced solid tumors (like lung, breast, or gastrointestinal cancers) who have not responded to stan…